Rosthornin B alleviates inflammatory diseases via directly targeting NLRP3
Yanqing Yang, Didi Liu, Hairuo Cao, Li Lu, Wei Zhang, Chenfei Liu, Yao Zeng, Feifei Shang, Ye Tao, Bao Zhao, Fengchao Wang, Tiantian Tang, Mengmeng Deng · 2024
Read Rosthornin B alleviates inflammatory diseases via directly targeting NLRP3 by Yanqing Yang, Didi Liu, Hairuo Cao, Li Lu, Wei Zhang, Chenfei Liu, Yao Zeng, Feifei Shang, Ye Tao, Bao Zhao, Fengchao Wang, Tiantian Tang, Mengmeng Deng (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11646051.txt.
Description
Yanqing Yang and co-authors report in 2024 that a natural compound from a mint family plant can block a key swelling switch in the body and ease several diseases in mice. Faulty firing of that switch drives many inflammatory diseases, and blocking it is a proven treatment idea. The team screened several plant compounds of one class against the switch.
One compound stood out as the strongest blocker. Tests showed it binds the switch protein itself. That binding keeps a partner protein from joining it, which stops the switch from being built and fired. In mice, the compound gave clear benefit in models of septic shock, belly swelling, and gut swelling, all driven by that switch. A natural product that hits the target directly is a strong lead for drug design.
Catalog record
| CREATOR | Yanqing Yang, Didi Liu, Hairuo Cao, Li Lu, Wei Zhang, Chenfei Liu, Yao Zeng, Feifei Shang, Ye Tao, Bao Zhao, Fengchao Wang, Tiantian Tang, Mengmeng Deng |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |